| 12377100 |
Toll like receptor modulator compounds |
Evangelos Aktoudianakis, Gregory Chin, Richard L. Mackman, Samuel E. Metobo, Michael R. Mish +1 more |
2025-08-05 |
|
| 12258346 |
Substituted 6-azabenzimidazole compounds |
Gayatri Balan, Mark J. Bartlett, Jayaraman Chandrasekhar, Julian A. Codelli, John H. Conway +14 more |
2025-03-25 |
|
| 11925631 |
Substituted 6-azabenzimidazole compounds |
Gayatri Balan, Mark J. Bartlett, Jayaraman Chandrasekhar, Julian A. Codelli, John H. Conway +12 more |
2024-03-12 |
$163,951,000 |
| 11897878 |
Substituted 6-azabenzimidazole compounds |
Gayatri Balan, Mark J. Bartlett, Jayaraman Chandrasekhar, Julian A. Codelli, John H. Conway +14 more |
2024-02-13 |
$118,355,000 |
| 11827609 |
Toll like receptor modulator compounds |
Gregory Chin, Richard L. Mackman, Michael R. Mish |
2023-11-28 |
$233,454,000 |
| 11203591 |
Substituted 6-azabenzimidazole compounds |
Gayatri Balan, Mark J. Bartlett, Jayaraman Chandrasekhar, Julian A. Codelli, John H. Conway +14 more |
2021-12-21 |
$210,993,000 |
| 11124487 |
Toll like receptor modulator compounds |
Gregory Chin, Richard L. Mackman, Michael R. Mish |
2021-09-21 |
$207,464,000 |
| 11071730 |
Substituted 6-azabenzimidazole compounds |
Gayatri Balan, Mark J. Bartlett, Jayaraman Chandrasekhar, Julian A. Codelli, John H. Conway +12 more |
2021-07-27 |
$231,761,000 |
| RE48150 |
Apoptosis signal-regulating kinase inhibitors |
Britton Kenneth Corkey, Gregory Notte |
2020-08-11 |
|
| 10640499 |
Toll like receptor modulator compounds |
Gregory Chin, Richard L. Mackman, Michael R. Mish |
2020-05-05 |
$800,316,000 |
| 10603318 |
Inhibitors of hepatitis C virus |
Eda Canales, Jeromy J. Cottell, Kapil Kumar Karki, Ashley Anne Katana, Darryl Kato +15 more |
2020-03-31 |
|
| 10507215 |
Compounds for the treatment of addiction |
Carina E. Cannizzaro, Michael Graupe, Juan A. Guerrero, Yafan Lu, Robert G. Strickley +1 more |
2019-12-17 |
|
| 10370342 |
Toll like receptor modulator compounds |
Gregory Chin, Richard L. Mackman, Michael R. Mish |
2019-08-06 |
$128,404,000 |
| 10335409 |
Inhibitors of hepatitis C virus |
Kyla Bjornson, Eda Canales, Jeromy J. Cottell, Kapil Kumar Karki, Ashley Anne Katana +15 more |
2019-07-02 |
|
| 10285990 |
Toll like receptor modulator compounds |
Evangelos Aktoudianakis, Gregory Chin, Richard L. Mackman, Samuel E. Metobo, Michael R. Mish +1 more |
2019-05-14 |
$195,322,000 |
| RE47351 |
2-(N-pyrazolo)adenosines with application as adenosine A2A receptor agonists |
Elfatih Elzein, Venkata P. Palle, Luiz Belardinelli |
2019-04-16 |
|
| 10259811 |
Tank-binding kinase inhibitor compounds |
Zhimin Du, Juan A. Guerrero, Joshua A. Kaplan, John E. Knox, Devan Naduthambi +4 more |
2019-04-16 |
$383,951,000 |
| RE47301 |
Process for preparing an A2A-adenosine receptor agonist and its polymorphs |
Elfatih Elzein, Robert Seemayer, Travis Lemons |
2019-03-19 |
|
| 10100058 |
Fused heterocyclic compounds as CaM kinase inhibitors |
Elfatih Elzein, Rao V. Kalla, Dmitry Koltun, Xiaofen Li, Eric Q. Parkhill +3 more |
2018-10-16 |
$159,225,000 |
| 10072001 |
Tank-binding kinase inhibitor compounds |
Zhimin Du, Juan A. Guerrero, Joshua A. Kaplan, John E. Knox, Devan Naduthambi +4 more |
2018-09-11 |
$246,857,000 |
| 10017501 |
Benzimidazole derivatives as bromodomain inhibitors |
Evangelos Aktoudianakis, Gregory Chin, Britton Kenneth Corkey, Jinfa Du, Kristyna M. Elbel +10 more |
2018-07-10 |
$525,460,000 |
| 10005774 |
Syk inhibitors |
Peter A. Blomgren, Jayaraman Chandrasekhar, Kevin S. Currie, Zhimin Du, Julie Farand +24 more |
2018-06-26 |
$460,376,000 |
| 9987295 |
Compounds for the treatment of addiction |
Carina E. Cannizzaro, Michael Graupe, Juan A. Guerrero, Yafan Lu, Robert G. Strickley +1 more |
2018-06-05 |
|
| 9920018 |
Fused heterocyclic compounds as ion channel modulators |
Michael Graupe, Yafan Lu |
2018-03-20 |
$486,978,000 |
| 9695192 |
Fused heterocyclic compounds as ion channel modulators |
Britton Kenneth Corkey, Elfatih Elzein, Robert Jiang, Rao V. Kalla, Dmitry Koltun +7 more |
2017-07-04 |
|